Receptor conversion impacts outcomes of different molecular subtypes of primary breast cancer.

Background:Although the conversion of clinically used breast cancer biomarkers such as estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) betwee...